W. French Anderson, "Genetics and Human Malleability," Hastings Center Report, 20:1 (January/February, 1990) 23. W. French Anderson, in a more recent work with John C. Fletcher, argues that the situation is changing. Whereas in the 1970s and 1980s there was a strong taboo against germline modification, in the 1990s that taboo is lifting. "Searches for cure and prevention of genetic disorders by germ-line therapy arise from principles of beneficence and non-maleficence, which create imperatives to relieve and prevent basic causes of human suffering. It follows from this ethical imperative that society ought not to draw a moral line between intentional germ-line therapy and somatic cell therapy. "Germ-Line Gene Therapy: A New Stage of Debate," Law, Medicine, and Health Care, 20:1/2 (Spring/Summer, 1992) 31.